Orthofix Medical (NASDAQ:OFIX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ...

BofA analyst Kevin Fischbeck upgraded UnitedHealth’s rating to ‘Buy’ from ‘Neutral’ and raised the price target to $450 from $420.

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, ...

During the last three months, 7 analysts shared their evaluations of Agilon Health (NYSE:AGL), revealing diverse outlooks from bullish to bearish. In the table below, you'll find a summary of their ...

Ratings for CVS Health (NYSE:CVS) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ...

Two thousand years ago, physicians in Egypt documented their patients’ symptoms and treatments on papyrus scrolls. These early medical records served a simple, localized purpose: they supported direct ...

11 analysts have expressed a variety of opinions on Teladoc Health (NYSE:TDOC) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their ...

The Health Information Management field is constantly evolving. Industry changes are vast and vary from the implementation of electronic health records to an increased focus on protected health ...